Search Press releases

3 Sep 2021

Transparency notification Wellington

Read More
3 Sep 2021

Disposals of own shares

Read More
27 Aug 2021

Disposals of own shares

Read More
27 Aug 2021

UCB showcases commitment to treatment and management of epilepsy at the 34th International Epilepsy Congress

Read More
24 Aug 2021

UCB Announces European Commission Approval of BIMZELX[®]▼ (bimekizumab) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis

Read More
20 Aug 2021

Disposals of own shares

Read More

Stay up-to-date on the latest news and information from UCB